These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 11345205

  • 1. Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
    Matsuzaki A, Ishii E, Nagatoshi Y, Eguchi H, Koga H, Yanai F, Inada H, Nibu K, Tamai Y, Akiyoshi K, Nakayama H, Hara T, Take H, Miyazaki S, Okamura J.
    Int J Hematol; 2001 Apr; 73(3):369-77. PubMed ID: 11345205
    [Abstract] [Full Text] [Related]

  • 2. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A, Ishii E, Okamura J, Eguchi H, Yoshida N, Yanai F, Inoue T, Miyake K, Ishihara T, Tsuboi C.
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
    Rivera GK, Hudson MM, Liu Q, Benaim E, Ribeiro RC, Crist WM, Pui CH.
    Blood; 1996 Aug 01; 88(3):831-7. PubMed ID: 8704238
    [Abstract] [Full Text] [Related]

  • 4. Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
    Kaleita TA, Reaman GH, MacLean WE, Sather HN, Whitt JK.
    Cancer; 1999 Apr 15; 85(8):1859-65. PubMed ID: 10223582
    [Abstract] [Full Text] [Related]

  • 5. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG, Savchenko VG, Kucher RA, Abakumov EM, Parovichnikova EN.
    Ter Arkh; 1992 Apr 15; 64(8):82-7. PubMed ID: 1440405
    [No Abstract] [Full Text] [Related]

  • 6. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
    Hann I, Vora A, Richards S, Hill F, Gibson B, Lilleyman J, Kinsey S, Mitchell C, Eden OB.
    Leukemia; 2000 Mar 15; 14(3):356-63. PubMed ID: 10720126
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH, Cassileth PA, Leong T, Hoagland HC, Bennett JM, Paietta E, Oken MM, Eastern Cooperative Oncology Group Study.
    Leuk Lymphoma; 2003 Sep 15; 44(9):1515-21. PubMed ID: 14565653
    [Abstract] [Full Text] [Related]

  • 10. Treating childhood acute lymphoblastic leukemia without cranial irradiation.
    Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV.
    N Engl J Med; 2009 Jun 25; 360(26):2730-41. PubMed ID: 19553647
    [Abstract] [Full Text] [Related]

  • 11. Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia.
    Cheuk DK, Shek TW, Chan GC, Lau YL, Ha SY, Chiang AK.
    Pediatr Blood Cancer; 2008 Mar 25; 50(3):636-9. PubMed ID: 16865683
    [Abstract] [Full Text] [Related]

  • 12. [Clinical trial of protocol-AL851 for children with high-risk acute lymphoblastic leukemia. Kyushu Yamaguchi Children's Cancer Study Group (KYCCSG)].
    Matsuzaki A, Ishii E, Ueda K, Yanai F, Nibu K, Take H, Koga H, Miyazaki S, Inoue T, Miyake K.
    Rinsho Ketsueki; 1994 Sep 25; 35(9):862-70. PubMed ID: 7967055
    [Abstract] [Full Text] [Related]

  • 13. Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial.
    Horibe K, Yumura-Yagi K, Kudoh T, Nishimura S, Oda M, Yoshida M, Komada Y, Hara J, Tawa A, Usami I, Tanizawa A, Kato K, Kobayashi R, Matsuo K, Hori H, Japan Association of Childhood Leukemia Study (JACLS), Japan.
    J Pediatr Hematol Oncol; 2017 Mar 25; 39(2):81-89. PubMed ID: 28169879
    [Abstract] [Full Text] [Related]

  • 14. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, Botsonis A, Tsangaris GT.
    J Pediatr Hematol Oncol; 2001 Dec 25; 23(9):591-7. PubMed ID: 11902303
    [Abstract] [Full Text] [Related]

  • 15. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
    Hongo T, Yajima S, Sakurai M, Horikoshi Y, Hanada R.
    Blood; 1997 Apr 15; 89(8):2959-65. PubMed ID: 9108416
    [Abstract] [Full Text] [Related]

  • 16. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.
    Haematologica; 1998 Sep 15; 83(9):791-9. PubMed ID: 9825576
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group.
    Kobayashi T, Tobinai K, Shimoyama M, Mikuni C, Konda S, Kozuru M, Araki K, Sai T, Fukuhara S, Matsumoto M, Aoki I, Deura K, Oyama A, Hotta T, Abe T, Toki H, Nagai M, Fukuda H, Niimi M, Yamaguchi N, Tajima K, Shirakawa S.
    Jpn J Clin Oncol; 1999 Jul 15; 29(7):340-8. PubMed ID: 10470659
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcomes of modified BFM-95 regimen in adults with newly diagnosed standard-risk acute lymphoblastic leukemia: a retrospective single-center study.
    Li C, Cai X, Chen X, Liang Y, Xia Z, Wang H.
    Int J Hematol; 2019 Oct 15; 110(4):458-465. PubMed ID: 31321731
    [Abstract] [Full Text] [Related]

  • 19. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group.
    Eur J Haematol; 2007 Feb 15; 78(2):102-10. PubMed ID: 17087744
    [Abstract] [Full Text] [Related]

  • 20. Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
    Grenzebach J, Schrappe M, Ludwig WD, Parwaresch R, Zimmermann M, Gadner H, Riehm H, Reiter A, BFM-Group.
    Ann Hematol; 2001 Feb 15; 80 Suppl 3():B73-6. PubMed ID: 11757713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.